• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Hurdle, CloudLIMS Partner to Augment Diagnostic Lab Capabilities

Share:

February 21, 2023

What You Should Know:

– Hurdle (a Chronomics Inc. brand), a global bio-infrastructure platform that powers end-to-end diagnostics for life sciences, labs and healthcare providers, and CloudLIMS, a leading SOC 2 compliant and ISO 9001:2015 certified lab informatics provider, announced today that the companies have entered into a strategic partnership marking the first integration between a Diagnostic as a Service (DaaS) platform and a Software-as-a-Service (SaaS) LIMS provider.

– The partnership brings together Hurdle’s remote diagnostic platform and CloudLIMS’s secure, purpose-built diagnostics LIMS to empower labs with the ability to offer at-home tests, and manage lab processes and data efficiently.

Helping Diagnostic Labs Stay Ahead of the Competition By Extending Remote Diagnostic Testing Services

As a result of this collaboration, Hurdle’s partner labs, such as reference labs and clinical diagnostic labs, will now be able to seamlessly manage lab data, automate workflows, and follow regulatory compliance, such as HIPAA, GDPR, CLIA, ISO 15189:2022.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Many labs today want to offer remote diagnostic services to provide direct-to-patient and direct-to-provider services, saving the time of both patients and providers. Diagnostic labs will now be able to extend their services to patients present in infectious disease hotspots, remote locations, and to underserved communities who are unable to travel to the lab location to get themselves tested. Labs can also improve their offering to existing B2B customers by providing Hurdle’s white-labeled kits.

“Labs using Hurdle are now able to enjoy a completely integrated experience while managing remote diagnostic journeys, which will have a positive impact for all customers,” said Tom Stubbs, co-founder and CEO of Hurdle. “The pandemic highlighted a global need for remote diagnostics while simultaneously exposing a fragmented infrastructure ill-equipped to meet the demand. Today, we’re happy to provide labs with fully integrated and efficient solutions through our dedicated diagnostics infrastructure so that they in turn can continue to support today’s providers and patients.”

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • The Mark Foundation for Cancer Research Announces 2023 Emerging Leader AwardsThe Mark Foundation for Cancer Research Announces 2023 Emerging Leader Awards
  • Why Providers are Key to Digital Therapeutic UptakeWhy Providers are Key to Digital Therapeutic Uptake
  • Why CVS-Aetna may be bad for your healthWhy CVS-Aetna may be bad for your health
  • Digital twin company Twin Health secures $50M.
  • Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170
  • Bioengineered Protein Drugs Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2027Bioengineered Protein Drugs Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2027
  • Equiva Health, Gilda’s Club, Healthcare Providers Leverage Affordable Broadband FundingEquiva Health, Gilda’s Club, Healthcare Providers Leverage Affordable Broadband Funding
  • Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting BiobankCrown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank

Trending This Week

  • Scotland’s Life Sciences Strategy Targets £25bn
  • Nectar Lifesciences Shares Surge on Buyback News
  • SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
  • Investment Guide Buy Sell Hold Five Stocks
  • Supriya Lifescience Stock Analysis and Outlook
  • Eiko Lifesciences Financial Performance Analysis 2025

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications